DaVitaDVA +1.72%89 Market Cap is $13,931 Mil as of Jun. 27, 2026. GuruFocus rates DVA with a GF Score™ of 89/100 and a GF Value™ of $173.84 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 697 Healthcare Providers & Services companies, DaVita ranks better than 98.85% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DaVita's share price for the quarter that ended in Mar. 2026 was $153.69. DaVita's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 66 Mil. Therefore, DaVita's market cap for the quarter that ended in Mar. 2026 was $10,172 Mil.
DaVita's quarterly market cap
declined
from Sep. 2025 ($9,431 Mil) to Dec. 2025 ($7,788 Mil) but then
increased
from Dec. 2025 ($7,788 Mil) to Mar. 2026 ($10,172 Mil).
DaVita's annual market cap
increased
from Dec. 2023 ($9,305 Mil) to Dec. 2024 ($12,044 Mil) but then
declined
from Dec. 2024 ($12,044 Mil) to Dec. 2025 ($7,788 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DaVita's Enterprise Value for Today is $28,289 Mil.
DaVita (NYSE:DVA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DaVita Market Cap Related Terms
DaVita Market Cap Historical Data
* Premium members only.
The historical data trend for DaVita's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DaVita's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Market Cap distribution charts can be found below:
* The bar in red indicates where DaVita's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DaVita's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (DVA) has a Market Cap of $13,931 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DaVita and its competitors. According to the industry distribution chart, DaVita ranks #8 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 1.1%.
Is DaVita's Market Cap too high?
DaVita's current Market Cap is $13,931 Mil. The Healthcare Providers & Services industry median Market Cap is 93.63. DaVita's value of $13,931 Mil is 14778.8% above this industry median. Based on the distribution chart, DaVita ranks #8 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Market Cap compare to EHC and THC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #8 out of 697 companies for Market Cap. This places DaVita in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 93.63. DaVita's value of $13,931 Mil is 14778.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaVita's current Market Cap of $13,931 Mil is 14778.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current Market Cap is $13,931 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (DVA) is currently considered Modestly Overvalued. The stock's GF Value™ is $173.84, compared to a current price of $217.04 — trading 24.9% above its estimated fair value. The current Market Cap is $13,931 Mil and 14778.8% above the Healthcare Providers & Services industry median of 93.63. DaVita's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DaVita (DVA), the current Market Cap is $13,931 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of $217.04 is trading 24.9% above its estimated GF Value™ of $173.84.
GuruFocus considers DaVita to be Modestly Overvalued.
Key valuation signals for DVA:
Market Cap: $13,931 Mil
GF Value™: $173.84 vs. price of $217.04 (24.9% above fair value)
Industry Position: 14778.8% above the Healthcare Providers & Services median (#8 of 697)
No single metric tells the full story. See the DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
89GF Score
Get the complete analysis for DVA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DVA has been successfully added to your 
